It is primarily used for adults with Type 2 Diabetes to: Lower Blood Sugar: Improve HbA1c levels when diet, exercise, or single-drug therapy (like Metformin) aren't enough. Heart Protection: Reduce the risk of cardiovascular death in adults with Type 2 Diabetes and established heart disease. Kidney Support: Help slow the progression of kidney issues associated with diabetes. Weight Management: Often preferred because it is weight-neutral or may lead to modest weight loss.
This "smart" combination works in two distinct ways: Empagliflozin (The Sugar Excretor): It works in the kidneys. Normally, kidneys filter sugar out and then pull it back into the blood. Empagliflozin blocks this reabsorption, forcing excess sugar to be flushed out of the body through urine. Linagliptin (The Hormone Booster): It works by increasing the levels of natural substances called incretins. These hormones help the pancreas release more insulin when blood sugar is high and signal the liver to stop producing unnecessary sugar.
Increased urination Ketoacidosis: Nausea, vomiting, stomach pain, or confusion. Urinary Tract Infections (UTIs) Pancreatitis: Severe, persistent stomach pain spreading to the back. Yeast infections (Genital) Dehydration: Dizziness, lightheadedness, or fainting. Nasopharyngitis (Cold-like symptoms) Joint Pain: Severe or persistent pain in joints.
This combination is used to improve blood sugar control in adults with type 2 diabetes. It combines an SGLT2 inhibitor (Empagliflozin) and a DPP-4 inhibitor (Linagliptin) to provide a dual-action approach to managing glucose levels.
Empagliflozin helps the kidneys remove excess sugar from the body through urine, while Linagliptin increases the levels of natural hormones that stimulate insulin production and reduce sugar production in the liver.
Yes. Empagliflozin, one of the components, is clinically proven to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with type 2 diabetes and established heart disease.
While not primarily a weight-loss drug, many patients experience modest weight loss because Empagliflozin flushes sugar (and calories) out of the body through urine. Linagliptin is generally weight-neutral.
It is typically taken once daily in the morning, with or without food. Taking it in the morning is often recommended because the diuretic effect of Empagliflozin may increase urination throughout the day.
Empagliflozin causes you to lose more fluid through urination. Drinking plenty of water is essential to prevent dehydration and reduce the risk of urinary tract infections (UTIs).
Common side effects include urinary tract infections (UTIs), genital yeast infections, increased urination, and cold-like symptoms (nasopharyngitis). Most are manageable with proper hygiene and hydration.
On its own, this combination has a low risk of causing hypoglycemia. However, if you take it alongside insulin or sulfonylureas, the risk of low blood sugar increases, and your doctor may need to adjust your dosages.
